In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus

The Journal of Antibiotics
Marcia S OsburneChristopher K Murphy

Abstract

Rifalazil is a novel rifamycin that, like other members of this class, inhibits bacterial transcription by targeting the beta subunit of prokaryotic DNA-dependent RNA polymerase. To address the high-frequency resistance seen with rifamycins, we assessed the ability of rifalazil, alone and in combination with vancomycin, to both kill cells and to suppress the appearance of resistant mutants in log and stationary phase Staphylococcus aureus cultures, using high cell densities in an in vitro kill curve model. We found that (1) rifalazil alone killed log-phase cultures more rapidly than rifampicin, but both drugs quickly selected for resistant mutants, (2) co-treatment of log phase cultures with rifalazil and vancomycin increased bacterial killing by about 3-Log10 over either drug used alone and delayed the appearance of rifamycin-resistant mutants, (3) rifalazil and vancomycin in combination killed stationary phase cultures

References

Nov 1, 1980·Antimicrobial Agents and Chemotherapy·R D PearsonS W Chapman
Feb 13, 1999·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·J M SchierholzG Pulverer
Oct 4, 2002·International Journal of Systematic and Evolutionary Microbiology·Robert MorseMatthew D Collins
Jan 31, 2003·Expert Opinion on Investigational Drugs·David M RothsteinBarry I Eisenstein
Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·Karl Drlica
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·Samuel A ShelburneRichard J Hamill

❮ Previous
Next ❯

Citations

May 31, 2006·Expert Opinion on Investigational Drugs·David M RothsteinLee Ann Campbell
Mar 20, 2010·Tuberculosis·Paul A AristoffH D Showalter
Feb 12, 2008·Trends in Pharmacological Sciences·Anthony R M Coates, Yanmin Hu
Oct 4, 2007·Archiv der Pharmazie·David M RothsteinSteven C Gilman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.